Stryker Corporation
SYK
Kedudukan dalam Saham
#200
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Harga Saham
$294.17
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$112.84B
Perubahan (1 hari)
0.27%
Perubahan (1 tahun)
-21.43%
Negara
US
Perdagangan Stryker Corporation (SYK)
Kategori
Healthcare
Margin Operasi untuk Stryker Corporation (SYK)
Margin Operasi pada October 2026 TTM: 22.03%
Menurut laporan kewangan dan harga saham terkini Stryker Corporation, margin operasi semasa (TTM) ialah 22.03%. Pada akhir 2024, margin operasi syarikat ialah 22.40%.
Sejarah Margin Operasi untuk Stryker Corporation dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | 22.03% | -1.65% |
| 2025 | 22.40% | 0.00% |
| 2024 | 22.40% | 7.28% |
| 2023 | 20.88% | 3.16% |
| 2022 | 20.24% | -8.00% |
| 2021 | 22.00% | 4.27% |
| 2020 | 21.10% | -7.29% |
| 2019 | 22.76% | -0.26% |
| 2018 | 22.82% | 2.61% |
| 2017 | 22.24% | -2.24% |
| 2016 | 22.75% | 0.49% |
| 2015 | 22.64% | -1.74% |
| 2014 | 23.04% | -0.99% |
| 2013 | 23.27% | 5.10% |
| 2012 | 22.14% | -6.70% |
| 2011 | 23.73% | -6.13% |
| 2010 | 25.28% | -1.40% |
| 2009 | 25.64% | 10.85% |
| 2008 | 23.13% | 4.57% |
| 2007 | 22.12% | 6.09% |
| 2006 | 20.85% | 5.14% |
| 2005 | 19.83% | 0.46% |
| 2004 | 19.74% | 5.17% |
| 2003 | 18.77% | 3.25% |
| 2002 | 18.18% | 0.22% |
| 2001 | 18.14% | 15.98% |
| 2000 | 15.64% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 17.03% | -99.23% |
US
|
|
| 17.86% | -99.19% |
IE
|
|
| 21.46% | -99.03% |
US
|
|
| 0.00% | - |
DE
|
|
| 28.09% | -98.72% |
US
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.